Suchergebnisse - "Massuti, B"

PubPharm (127)

1

Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trial

enthalten in: ESMO open | 2024

von Michels, S. | Massutí, B. | Vasyliv, I. | +29

2

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations : the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Soo, R. | Han, J. | Dafni, U. | +98

3

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Peters, S. | Pujol, J. | Dafni, U. | +116

4

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells : the randomised phase II VISNÚ-2 study

enthalten in: ESMO open | 2021

von Sastre, J. | García-Alfonso, P. | Viéitez, J. | +81

5

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer : A Retrospective Pooled Analysis

enthalten in: Drugs & aging | 2021

von García-Alfonso, P. | Díaz-Rubio, E. | Abad, A. | +118

6

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer : a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

enthalten in: BMC cancer | 2019

von Carrato, A. | Benavides, M. | Massutí, B. | +16

7

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

enthalten in: BMC cancer | 2019

von Carrato, A. | Benavides, M. | Massutí, B. | +16

8

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

enthalten in: BMC cancer | 2019

von Carrato, A. | Benavides, M. | Massutí, B. | +16

9

Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Vidal, J. | Bellosillo, B. | Santos Vivas, C. | +18

10

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC) : a pharmacogenetic-based randomized phase II trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Abad, A. | Martínez-Balibrea, E. | Viéitez, J. | +17

CommentIn: Ann Oncol. 2018 Feb 1;29(2):293-295. - PMID 29236957

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]